Pathophysiology, Treatment, and Prevention of Catheter-Associated Urinary Tract Infection

Top Spinal Cord Inj Rehabil. 2019 Summer;25(3):228-240. doi: 10.1310/sci2503-228.

Abstract

Urinary tract infections (UTIs) are among the most common microbial infections in humans and represent a substantial burden on the health care system. UTIs can be uncomplicated, as when affecting healthy individuals, or complicated, when affecting individuals with compromised urodynamics and/or host defenses, such as those with a urinary catheter. There are clear differences between uncomplicated UTI and catheter-associated UTI (CAUTI) in clinical manifestations, causative organisms, and pathophysiology. Therefore, uncomplicated UTI and CAUTI cannot be approached similarly, or the risk of complications and treatment failure may increase. It is imperative to understand the key aspects of each condition to develop successful treatment options and improve patient outcomes. Here, we will review the epidemiology, pathogen prevalence, differential mechanisms used by uropathogens, and treatment and prevention of uncomplicated UTI and CAUTI.

Keywords: CAUTI; prevalence; susceptibility; uncomplicated UTI; uropathogens.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Catheter-Related Infections / microbiology*
  • Catheter-Related Infections / prevention & control*
  • Humans
  • Immunotherapy
  • Immunotherapy, Active
  • Urinary Tract Infections / microbiology*
  • Urinary Tract Infections / prevention & control*

Substances

  • Anti-Bacterial Agents